Effect of Incidental Findings Information on Lung Cancer Screening Intent
1 other identifier
interventional
419
1 country
1
Brief Summary
This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or without and indicate their intent to pursue lung cancer screening. Hypothesis: Inclusion of incidental findings in a decision aid will decrease intent to screen among participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedStudy Start
First participant enrolled
July 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2020
CompletedDecember 10, 2020
December 1, 2020
1 month
May 28, 2020
December 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of individuals who plan to pursue lung cancer screening
This will be assessed by a survey item where participants indicate their response to a statement of whether they plan to pursue lung cancer screening, with answer choices being strongly agree, agree, disagree and strongly disagree. Comparison between the intervention and control groups will be made.
Day 1
Secondary Outcomes (6)
Mean score on scale of lung cancer screening knowledge
Day 1
Mean rating of benefit and harms of screening
Day 1
Percentage of Time Lung Cancer Screening Benefit and Harms are ranked first and last
Day 1
Mean ranking of benefit and harms of screening
Day 1
Percentage of time each lung cancer screening harm is ranked highest of the five potential harms
Day 1
- +1 more secondary outcomes
Study Arms (2)
Decision aid with incidental findings information
EXPERIMENTALParticipants in this arm will view a video decision aid that include information on incidental findings in lung cancer screening.
Decision aid without incidental findings information
ACTIVE COMPARATORParticipants in this arm will view a video decision aid that does not include information on incidental findings in lung cancer screening.
Interventions
The intervention consists of a previously tested and developed brief lung cancer screening video decision aid with the addition of information on incidental findings for lung cancer screening.
The intervention consists of a previously tested and developed brief lung cancer screening video decision aid that does not include information on incidental findings.
Eligibility Criteria
You may qualify if:
- year old male or female
- Current or former smoker who quit within the last 15 years
- At least 30 pack years of smoking
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
Related Publications (1)
Clark SD, Reuland DS, Brenner AT, Jonas DE. Effect of Incidental Findings Information on Lung Cancer Screening Intent: a Randomized Controlled Trial. J Gen Intern Med. 2022 Nov;37(14):3676-3683. doi: 10.1007/s11606-022-07409-4. Epub 2022 Feb 2.
PMID: 35113322DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen Clark, MD
University of North Carolina, Chapel Hill
- STUDY DIRECTOR
Daniel Jonas, MD, MPH
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 16, 2020
Study Start
July 16, 2020
Primary Completion
August 22, 2020
Study Completion
August 22, 2020
Last Updated
December 10, 2020
Record last verified: 2020-12